Assess topical Rx response with amitriptyline and ketamine in chemo peripheral neuropathy (ATTRACT-CPN)

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://clinicaltrials.gov/show/NCT00471445

2. Intervention

   Amiltriptyline and ketamine cream

3. Intervention

   Placebo

4. Resource Description

   Protocol ID: URCC-06-05

5. Contact

   Berenberg, Jeffrey

6. PI

   Berenberg, Jeffrey

7. Topic

   cancer

8. Topic

   peripheral nervous system disease

9. Study Population

   Males and females age 18 and older with history of cancer, pain, numbness, or tingling in the hands or feet beginning in association with a cancer chemotherapy agent, no preexisting or history of peripheral neuropathy due to any cause other than chemotherapy, stable systemic metastases and/or bone involvement AND has not received chemotherapy within 3 months of screening assessment, and no concurrent active chemotherapy in the adjuvant setting or for progressive systemic disease.

10. Website(s)

    http://clinicaltrials.gov/ct2/bye/_QoPWw4lZXcgkdNgzwpxUd-BZBcaedNz0B7aWwNzkdoRZHHy4VSWEg0tL/IVcaedNz0B7EJioyeB7EJw-Hmd7GSTD3NwN9mnoPl6D3KB1PedcxkdY34B7x061nJD7xFihzWi1Pzy-RJ8jPPE_OJ6hGWB7ykwc8

11. Funded by

    University of Rochester Cancer Center

12. Phase

    Phase 3 clinical trial

13. Performed by

    Clinical Protocol & Data Management Shared Resource